Enabling Factors in Successful Product Development by Tang, Victor, Liu, Bing, Kellam, Benjamin A., Otto, Kevin N., Seeing, Warren P.

Subjects: “…PD success factors…”
Get full text

Enabling Factors in Successful Product Development by Tang, Victor, Liu, Bing, Kellam, Benjamin A., Otto, Kevin N., Seering, Warren P.

Subjects: “…PD success factors…”
Get full text

Self-care or assisted PD: development of a new approach to evaluate manual peritoneal dialysis practice ability by Jiaying Huang, Aiping Gu, Na Li, Yanna He, Weizhen Xie, Wei Fang, Jiangzi Yuan, Na Jiang

Subjects: Get full text

Postural Instability in Parkinson’s Disease: A Review by Bhavana Palakurthi, Sindhu Preetham Burugupally

Subjects: Get full text

Research Progress of PD-1/PD-L1 Checkpoint Inhibitors in (Neo) Adjuvant Therapy for Malignant Melanoma by ZOU Hanhui, Li Tao

Subjects: Get full text

In Search of Better Peptide-(Derived from PD-L2)-Based Immune Checkpoint Inhibitors by Boris Klebansky, Marina Backer, Vitaliy Gorbatyuk, Olga Vinogradova, Joseph Backer

Subjects: “…PD-1…”
Get full text

High Quality Performance of Novel Immunoassays for the Sensitive Quantification of Soluble PD-1, PD-L1 and PD-L2 in Blood by Kimberly Krueger, Zsuzsanna Mayer, Miriam Gerckens, Stefan Boeck, Peter Luppa, Stefan Holdenrieder

Subjects: “…PD-1…”
Get full text

TLR9 Mediated Tumor-Stroma Interactions in Human Papilloma Virus (HPV)-Positive Head and Neck Squamous Cell Carcinoma Up-Regulate PD-L1 and PD-L2 by Paramita Baruah, Paramita Baruah, Jessica Bullenkamp, Philip O. G. Wilson, Michael Lee, Juan Carlos Kaski, Ingrid E. Dumitriu

Subjects: Get full text

Unknown PD distinction in HVAC/HVDC by antenna-sensor with pulse sequence analysis by S. M. Kayser Azam, Mohamadariff Othman, Hazlee Azil Illias, Tarik Abdul Latef, Daniar Fahmi, Wong Jee Keen Raymond, Wan Nor Liza Wan Mahadi, A. K. M. Zakir Hossain, M.Z.A. Abd. Aziz, Ahmad Ababneh

Subjects: Get full text

Programmed Cell Death-1 and Its Ligands as Targets for Therapy of Multiple Myeloma Patients by Karczmarczyk A, Korpysz M, Bilska S, Purkot J, Hus M, Giannopoulos K

Subjects: “…pd-1…”
Get full text

New Synthetic Partial Discharge Calibrator for Qualification of Partial Discharge Analyzers for Insulation Diagnosis of HVDC and HVAC Grids by Abderrahim Khamlichi, Fernando Garnacho, Pascual Simón

Subjects: “…PD calibrator…”
Get full text

Discovery of Novel Small-Molecule Inhibitors of PD-1/PD-L1 Interaction via Structural Simplification Strategy by Hongbo Zhang, Yu Xia, Chunqiu Yu, Huijie Du, Jinchang Liu, Hui Li, Shihui Huang, Qihua Zhu, Yungen Xu, Yi Zou

Subjects: Get full text

PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma by Yu-Min Zhong, Yu-Min Zhong, Yu-Min Zhong, Kai Yin, Kai Yin, Yu Chen, Yu Chen, Zhi Xie, Zhi Xie, Zhi-Yi Lv, Zhi-Yi Lv, Jin-Ji Yang, Xue-Ning Yang, Qing Zhou, Bin-Chao Wang, Wen-Zhao Zhong, Ling-Ling Gao, Ling-Ling Gao, Wen-Bin Zhou, Ji Chen, Ji Chen, Hai-Yan Tu, Ri-Qiang Liao, Dong-Kun Zhang, Shui-Lian Zhang, Shui-Lian Zhang, Dan-Xia Lu, Dan-Xia Lu, Hong-Bo Zheng, Heng-Hui Zhang, Yi-Long Wu, Xu-Chao Zhang, Xu-Chao Zhang, Xu-Chao Zhang, Xu-Chao Zhang

Subjects: Get full text

Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy by Chunmeng Wang, Fengxia Shi, Yang Liu, Yajing Zhang, Liang Dong, Xiang Li, Chuan Tong, Yao Wang, Liping Su, Jing Nie, Weidong Han

Subjects: Get full text

Robust Preanalytical Performance of Soluble PD-1, PD-L1 and PD-L2 Assessed by Sensitive ELISAs in Blood by Kimberly Krueger, Zsuzsanna Mayer, Marc Kottmaier, Miriam Gerckens, Stefan Boeck, Peter Luppa, Stefan Holdenrieder

Subjects: “…PD-1…”
Get full text

PD0325901, an ERK inhibitor, enhances the efficacy of PD-1 inhibitor in non-small cell lung carcinoma by Min Luo, Yuhui Xia, Fang Wang, Hong Zhang, Danting Su, Chaoyue Su, Chuan Yang, Shaocong Wu, Sainan An, Suxia Lin, Liwu Fu

Subjects: Get full text

Expression patterns of immune checkpoints in acute myeloid leukemia by Cunte Chen, Chaofeng Liang, Shunqing Wang, Chi Leong Chio, Yuping Zhang, Chengwu Zeng, Shaohua Chen, Caixia Wang, Yangqiu Li

Subjects: “…PD-1…”
Get full text

The recent guidelines for pharmacotherapy of Parkinson’s Disease by Karabin Tomasz, Biala Grazyna, Kruk-Slomka Marta

Subjects: “…parkinson’s disease (pd)…”
Get full text

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer by Janice M. Mehnert, Andrea Varga, Marcia S. Brose, Rahul R. Aggarwal, Chia-Chi Lin, Amy Prawira, Filippo de Braud, Kenji Tamura, Toshihiko Doi, Sarina A. Piha-Paul, Jill Gilbert, Sanatan Saraf, Pradeep Thanigaimani, Jonathan D. Cheng, Bhumsuk Keam

Subjects: Get full text

Longitudinal fluctuations in PD1 and PD-L1 expression in association with changes in anti-viral immune response in chronic hepatitis B by Wenjin Zhang, Chuanhui Peng, Yunle Wan, Lateef Shaikh, Shusen Zheng

Subjects: “…PD1…”
Get full text